1. Lin, Shuye, Xu, Hanli, Qin, Lin, Ren, Jianke, Huang, Jiaqiang. 2023. UHRF1/DNMT1-MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer. In Acta pharmaceutica Sinica. B, 13, 2086-2106. doi:10.1016/j.apsb.2023.02.015. https://pubmed.ncbi.nlm.nih.gov/37250150/
2. Lin, Bonan, Zhou, Xiaomeng, Lin, Shuye, Guo, Mingzhou, Huang, Jiaqiang. 2017. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma. In Journal of molecular medicine (Berlin, Germany), 95, 1237-1249. doi:10.1007/s00109-017-1578-5. https://pubmed.ncbi.nlm.nih.gov/28844099/
3. Rowen, Lee, Williams, Eleanor, Glusman, Gustavo, Hood, Leroy, Trask, Barbara J. 2005. Interchromosomal segmental duplications explain the unusual structure of PRSS3, the gene for an inhibitor-resistant trypsinogen. In Molecular biology and evolution, 22, 1712-20. doi:. https://pubmed.ncbi.nlm.nih.gov/15901841/
4. Rosendahl, Jonas, Teich, Niels, Kovacs, Peter, Sahin-Tóth, Miklós, Witt, Heiko. 2010. Complete analysis of the human mesotrypsinogen gene (PRSS3) in patients with chronic pancreatitis. In Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 10, 243-9. doi:10.1159/000243769. https://pubmed.ncbi.nlm.nih.gov/20484962/
5. Masson, Emmanuelle, Le Maréchal, Cédric, Chen, Jian-Min, Férec, Claude. . Absence of mesotrypsinogen gene (PRSS3) copy number variations in patients with chronic pancreatitis. In Pancreas, 37, 227-8. doi:10.1097/MPA.0b013e3181654b6a. https://pubmed.ncbi.nlm.nih.gov/18665091/
6. Rattanakomol, Patthaya, Srimanote, Potjanee, Tongtawe, Pongsri, Supasorn, Oratai, Thanongsaksrikul, Jeeraphong. 2022. Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication. In Scientific reports, 12, 12846. doi:10.1038/s41598-022-17272-2. https://pubmed.ncbi.nlm.nih.gov/35896602/
7. Hockla, Alexandra, Miller, Erin, Salameh, Moh'd A, Radisky, Derek C, Radisky, Evette S. . PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. In Molecular cancer research : MCR, 10, 1555-66. doi:10.1158/1541-7786.MCR-12-0314. https://pubmed.ncbi.nlm.nih.gov/23258495/